🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study (EPOCH-TECT) was a single-center, randomized, open-label, blinde...
Status
Completed
Location
Affiliated Hospital of Xuzhou Medical University
Start Date
2025-12-20
Trial ID
NCT07295366
Treatments Being Tested
The primary objective was to evaluate the effect of 12 weeks of subcutaneou...
Status
Completed
Location
Research Site
Start Date
2013-01-24
Trial ID
NCT01763905
Treatments Being Tested
The primary objective was to evaluate the effect of treatment with evolocum...
Status
Unknown
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2019-09-11
Trial ID
NCT04087915
Treatments Being Tested
Spastic paraplegia type 5 (SPG5) is a rare subtype of hereditary spastic pa...
Status
Unknown
Location
Department of Neurology , First Affiliated Hospital Fujian Medical University
Start Date
2019-09-29
Trial ID
NCT04101643
Treatments Being Tested
To evaluate the effect of 12 weeks of subcutaneous (SC) evolocumab (AMG 145...
Status
Completed
Location
Research Site
Start Date
2011-07-01
Trial ID
NCT01380730
Treatments Being Tested
This study is a Phase IIa clinical trial initiated by the researchers, whic...
Status
Completed
Location
Department of Neurology
Start Date
2025-10-30
Trial ID
NCT07301372
Treatments Being Tested
The primary objective of the study was to evaluate the effect of 12 weeks o...
Status
Completed
Location
Research Site
Start Date
2016-02-27
Trial ID
NCT02634580
Treatments Being Tested
The primary objective of this study was to evaluate the effect of 12 weeks ...
Status
Completed
Location
Research Site
Start Date
2016-04-14
Trial ID
NCT02662569
Treatments Being Tested
The primary objective of this study was to assess users' ability to adminis...
Status
Completed
Location
Research Site
Start Date
2013-07-11
Trial ID
NCT01879319
Treatments Being Tested
The primary objective was to evaluate the effect of 12 weeks of evolocumab ...
Status
Completed
Location
Research Site
Start Date
2013-02-07
Trial ID
NCT01763918
Treatments Being Tested